IRIS UniCatt

Metafuni, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.026
NA - Nord America 1.855
AS - Asia 1.093
SA - Sud America 225
AF - Africa 30
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.824
DE - Germania 531
SE - Svezia 430
SG - Singapore 418
IT - Italia 364
CN - Cina 360
BR - Brasile 204
FR - Francia 166
IE - Irlanda 119
GB - Regno Unito 98
IN - India 90
ID - Indonesia 81
FI - Finlandia 74
UA - Ucraina 71
RU - Federazione Russa 52
KR - Corea 44
CA - Canada 24
CI - Costa d'Avorio 21
BE - Belgio 20
NL - Olanda 20
TR - Turchia 20
AT - Austria 17
HK - Hong Kong 17
CZ - Repubblica Ceca 16
CO - Colombia 7
ES - Italia 7
TH - Thailandia 7
PL - Polonia 5
RO - Romania 5
SA - Arabia Saudita 5
VN - Vietnam 5
BD - Bangladesh 4
EC - Ecuador 4
IL - Israele 4
JP - Giappone 4
LV - Lettonia 4
MA - Marocco 4
MX - Messico 4
AM - Armenia 3
AR - Argentina 3
CH - Svizzera 3
IQ - Iraq 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
PY - Paraguay 2
TW - Taiwan 2
ZA - Sudafrica 2
BG - Bulgaria 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.232
Salva come PNG Salva come JPEG
Città #
Chandler 402
Singapore 274
Ashburn 142
Dublin 117
Jakarta 80
Rome 72
San Mateo 68
Jacksonville 62
Milan 55
Hyderabad 53
Los Angeles 52
Houston 49
Nanjing 49
Dearborn 48
Florence 48
Hefei 47
New York 47
Beijing 46
Seoul 44
Ann Arbor 42
Marseille 42
Chicago 39
Wilmington 38
Moscow 37
Frankfurt am Main 36
Munich 35
Helsinki 33
Lancaster 33
Princeton 33
Cattolica 30
Nürnberg 29
Boston 28
The Dalles 28
Bremen 26
Nanchang 22
Abidjan 21
Seattle 21
Brussels 20
Nuremberg 20
Santa Clara 19
São Paulo 18
Lappeenranta 16
London 16
Toronto 16
Hong Kong 15
Izmir 15
Guangzhou 14
Woodbridge 14
Fairfield 13
Lawrence 13
Tianjin 13
Boardman 12
Brno 12
Pune 12
Norwalk 11
Washington 11
Belo Horizonte 10
Düsseldorf 10
Portsmouth 10
Redwood City 10
Shanghai 10
Augusta 9
Lauterbourg 9
Rio de Janeiro 9
Turku 9
Vienna 9
Arezzo 8
Mountain View 8
Falkenstein 7
Porto Alegre 7
Redmond 7
San Francisco 7
Shenyang 7
Amsterdam 6
Council Bluffs 6
Leawood 6
Naples 6
Auburn Hills 5
Brasília 5
Brooklyn 5
Curitiba 5
Edinburgh 5
Kunming 5
Paris 5
Roubaix 5
Stockholm 5
Tampa 5
Zhengzhou 5
Bangkok 4
Changsha 4
Charlotte 4
Columbus 4
Falls Church 4
Fremont 4
Newark 4
Philadelphia 4
Riga 4
Tokyo 4
Atlanta 3
Bexley 3
Totale 2.879
Salva come PNG Salva come JPEG
Nome #
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 177
Correlation between paraproteinaemia and viral reactivation after allo-SCT 154
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 149
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 139
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 135
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 123
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 110
Hyperleukocytosis and leukostasis: management of a medical emergency 109
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 107
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 106
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 106
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 100
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 96
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 93
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 93
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 84
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 83
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 81
Changes in protein serum levels during stem cell transplantation 80
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 80
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 79
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 79
Unrelated cord blood transplantation and post-transplant cyclophosphamide 77
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 77
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 77
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 76
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 75
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 75
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 73
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 73
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 71
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 70
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 69
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 69
Unrelated cord blood transplantation and post-transplant cyclophosphamide 67
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 67
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 64
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 64
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 61
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 54
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 54
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 53
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 53
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 51
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 50
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 50
Second haploidentical stem cell transplantation for primary graft failure 50
Reducing infectious complications after allogeneic stem cell transplant 49
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 48
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 48
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 47
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 47
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 46
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 45
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study 42
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 42
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 41
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 41
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 39
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 37
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 36
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 35
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 35
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 34
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 34
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 33
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 32
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 32
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 31
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation 30
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 29
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 29
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 29
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 28
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 28
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 28
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants 27
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 25
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 24
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 22
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 20
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 19
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 12
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience 10
MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings 9
Totale 5.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 0 0 35 25
2020/2021237 9 19 10 15 20 17 15 12 31 10 72 7
2021/2022488 34 14 29 24 43 12 9 72 19 45 98 89
2022/20231.216 188 159 72 185 85 135 88 84 102 51 54 13
2023/2024776 29 156 45 60 21 94 65 43 17 56 85 105
2024/20251.640 47 52 127 101 170 65 89 85 215 218 471 0
Totale 5.365